Up-regulation of adenosine A1 receptors in frontal cortex from Pick's disease cases

European Journal of Neuroscience

Volumn 26, Issue 12, 2007, Pages 3501-3508

  Albasanz, José Luis ^a   Rodríguez, Agustín ^b   Ferrer, Isidro ^b,c   Martín, Mairena ^a,d  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^b Facultad de Medicina   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d Analytical Chemistry and Food Science Dept   (Spain)

Author keywords

Adenylyl cyclase; Dementia; Human; PiD; Post mortem

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; ADENYLATE CYCLASE; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATE;

AGED; ARTICLE; AUTOPSY; BRAIN; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; LIGAND BINDING; MALE; OCCIPITAL CORTEX; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ADENOSINE; ADENYLATE CYCLASE; AGED; BRAIN; CADAVER; CELL MEMBRANE; FEMALE; FORSKOLIN; FRONTAL LOBE; HUMANS; MALE; OCCIPITAL LOBE; PICK DISEASE OF THE BRAIN; RECEPTOR, ADENOSINE A1; RNA, MESSENGER; UP-REGULATION; XANTHINES;

EID: 36949020805     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2007.05965.x     Document Type: Article

References (61)

1. Abbracchio, M.P. Cattabeni, F. (1999) Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases. Ann. NY Acad. Sci., 890, 79 92.
2. Albasanz, J.L., Dalfo, E., Ferrer, I. Martin, M. (2005) Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes. Neurobiol. Dis., 20, 685 693.
3. 2A receptors are up-regulated in Pick's disease frontal cortex. Brain Pathol., 16, 249 255.
4. Angulo, E., Casado, V., Mallol, J., Canela, E.I., Vinals, F., Ferrer, I., Lluis, C. Franco, R. (2003) A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation. Brain Pathol., 13, 440 451.
5. Arai, T., Ikeda, K., Akiyama, H., Tsuchiya, K., Del Tredici, K., Sundarraj, S., Clark, C., Trojanowski, J.Q. Lee, V.M. (2003) Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol., 105, 489 498.
6. Bauer, A., Holschbach, M.H., Meyer, P.T., Boy, C., Herzog, H., Olsson, R.A., Coenen, H.H. Zilles, K. (2003) In vivo imaging of adenosine A1 receptors in the human brain with [18F]CPFPX and positron emission tomography. Neuroimage, 19, 1760 1769.
7. Bruno, V., Battaglia, G., Copani, A., D'Onofrio, M., Di Iorio, P., De Blasi, A., Melchiorri, D., Flor, P.J. Nicoletti, F. (2001) Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs. J. Cereb. Blood Flow Metab., 21, 1013 1033.
8. Cunha, R.A. (2005) Neuroprotection by adenosine in the brain: from A1 receptor activation to A2A receptor blockade. Purinergic Signal, 1, 111 134.
9. Dalfó, E., Albasanz, J.L., Martin, M. Ferrer, I. (2004) Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular alpha-synuclein/ phospholipase C (PLCbeta1) interactions. Brain Pathol., 14, 388 398.
10. Dalfó, E., Albasanz, J.L., Rodriguez, A., Martín, M. Ferrer, I. (2005) Abnormal group I metabotropic glutamate receptor expression and signalling in the frontal cortex in Pick disease. J. Neurophatol. Exp. Neurol., 64, 638 647.
11. Deckert, J., Abel, F., Kunig, G., Hartmann, J., Senitz, D., Maier, H., Ransmayr, G. Riederer, P. (1998) Loss of human hippocampal adenosine A1 receptors in dementia: evidence for lack of specificity. Neurosci. Lett., 244, 1 4.
12. Deckert, J. Gleiter, C.H. (1994) Adenosine: an endogenous neuroprotective metabolite and neuromodulator. J. Neural Transm. Suppl., 43, 23 31.
13. Delacourte, A., Robitaille, Y., Sergeant, N., Buee, L., Hof, P.R., Wattez, A., Laroche-Cholette, A., Mathieu, J., Chagnon, P. Gauvreau, D. (1996) Specific pathological Tau protein variants characterize Pick's disease. J. Neuropathol. Exp. Neurol., 55, 159 168.
14. Dickson, D. (1998) Pick's disease: a modern approach. Brain Pathol., 8, 339 354.
15. Dodd, P.R., Watson, W.E. Johnston, G.A. (1986) Adenosine receptors in post-mortem human cerebral cortex and the effect of carbamazepine. Clin. Exp. Pharmacol. Physiol., 13, 711 722.
16. Dunwiddie, T.V. Masino, S.A. (2001) The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci., 24, 31 55.
17. Fastbom, J., Pazos, A. Palacios, J.M. (1987a) The distribution of adenosine A1 receptors and 5′-nucleotidase in the brain of some commonly used experimental animals. Neuroscience, 22, 813 826.
18. Fastbom, J., Pazos, A., Probst, A. Palacios, J.M. (1986) Adenosine A1-receptors in human brain: characterization and autoradiographic visualization. Neurosci. Lett., 65, 127 132.
19. Fastbom, J., Pazos, A., Probst, A. Palacios, J.M. (1987b) Adenosine A1 receptors in the human brain: a quantitative autoradiographic study. Neuroscience, 22, 827 839.
20. Ferroni, S., Marchini, C., Ogata, T. Schubert, P. (2002) Recovery of deficient cholinergic calcium signaling by adenosine in cultured rat cortical astrocytes. J. Neurosci. Res., 68, 615 621.
21. Francis, P.T., Palmer, A.M., Snape, M. Wilcock, G.K. (1999) The cholinergic hypothesis of Alzheimer's disease: a review of progress. J. Neurol. Neurosurg. Psychiatry, 66, 137 147.
22. Fredholm, B.B., Chen, J.F., Cunha, R.A., Svenningsson, P. Vaugeois, J.M. (2005) Adenosine and brain function. Int. Rev. Neurobiol., 63, 191 270.
23. Fredholm, B.B., IJzerman, A.P., Jacobson, K.A., Klotz, K.N. Linden, J. (2001a) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev., 53, 527 552.
24. Fredholm, B.B., Irenius, E., Kull, B. Schulte, G. (2001b) Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem. Pharmacol., 61, 443 448.
25. Fukumitsu, N., Ishii, K., Kimura, Y., Oda, K., Sasaki, T., Mori, Y. Ishiwata, K. (2003) Imaging of adenosine A1 receptors in the human brain by positron emission tomography with [11C]MPDX. Ann. Nucl. Med., 17, 511 555.
26. Fukumitsu, N., Ishii, K., Kimura, Y., Oda, K., Sasaki, T., Mori, Y. Ishiwata, K. (2005) Adenosine A1 receptor mapping of the human brain by PET with 8-dicyclopropylmethyl-1-11C-methyl-3-propylxanthine. J. Nucl. Med., 46, 32 37.
27. Glass, M., Faull, R.L. Dragunow, M. (1996) Localisation of the adenosine uptake site in the human brain: a comparison with the distribution of adenosine A1 receptors. Brain Res., 710, 79 91.
28. Higuchi, R., Fockler, C., Dollinger, G. Watson, R. (1993) Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology, 11, 1026 1030.
29. Ikeda, M., Mackay, K.B., Dewar, D. McCulloch, J. (1993) Differential alterations in adenosine A1 and kappa 1 opioid receptors in the striatum in Alzheimer's disease. Brain Res., 616, 211 217.
30. Jansen, K.L., Faull, R.L., Dragunow, M. Synek, B.L. (1990) Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors - an autoradiographic study. Neuroscience, 39, 613 627.
31. Jockers, R., Linder, M.E., Hohenegger, M., Nanoff, C., Bertin, B., Strosberg, A.D., Marullo, S. Freissmuth, M. (1994) Species difference in the G protein selectivity of the human and bovine A1-adenosine receptor. J. Biol. Chem., 269, 32077 32084.
32. John, D. Fox, I.H. (1985) Characteristics of high-affinity and low-affinity adenosine binding sites in human cerebral cortex. J. Laboratory. Clin. Med., 106, 401 407.
33. Jumpsen, J., Lien, E.L., Goh, Y.K. Clandinin, M.T. (1997) Small changes of dietary (n-6) and (n-3) /fatty acid content ration alter phosphatidylethanolamine and phosphatidylcholine fatty acid composition during development of neuronal and glial cells in rats. J. Nutr., 127, 724 731.
34. Kalaria, R.N., Sromek, S., Wilcox, B.J. Unnerstall, J.R. (1990) Hippocampal adenosine A1 receptors are decreased in Alzheimer's disease. Neurosci. Lett., 118, 257 260.
35. Lea, P.M. 4th, Faden, A.I. (2003) Modulation of metabotropic glutamate receptors as potential treatment for acute and chronic neurodegenerative disorders. Drug News Perspect., 16, 513 522.
36. Leon, D., Albasanz, J.L., Ruiz, M.A., Fernandez, M. Martin, M. (2002) Adenosine A1 receptor down-regulation in mothers and fetal brain after caffeine and theophylline treatments to pregnant rats. J. Neurochem., 82, 625 634.
37. Leon, D., Albasanz, J.L., Ruiz, M.A. Martin, M. (2005) Chronic caffeine or theophylline intake during pregnancy inhibits A1 receptor function in the rat brain. Neuroscience, 131, 481 489.
38. Markesbery, W.R. (1998) Pick's disease. In Markesbery, W. (ed.), Neuropathology of Dementing Disorders. Arnold, London, pp 145 157.
39. de Mendonca, A., Sebastiao, A.M. Ribeiro, J.A. (2000) Adenosine: does it have a neuroprotective role after all? Brain Res. Brain Res. Rev., 33, 258 274.
40. Meyer, P.T., Bier, D., Holschbach, M.H., Boy, C., Olsson, R.A., Coenen, H.H., Zilles, K. Bauer, A. (2004) Quantification of cerebral A1 adenosine receptors in humans using [18F]CPFPX and PET. J. Cereb. Blood Flow Metab., 24, 323 333.
41. Muntané, G., Dalfo, E., Martinez, A., Rey, M.J., Avila, J., Perez, M., Portero, M., Pamplona, R., Ayala, V. Ferrer, I. (2006) Glial fibrillary acidic protein is a major target of glycoxidative and lipoxidative damage in Pick's disease. J. Neurochem., 99, 177 185.
42. Murphy, K.M. Snyder, S.H. (1982) Heterogeneity of adenosine A1 receptor binding in brain tissue. Mol. Pharmacol., 22, 250 257.
43. Nakata, H. (1992) Biochemical and immunological characterization of A1 adenosine receptors purified from human brain membranes. Eur. J. Biochem., 206, 171 177.
44. Puig, B., Viñals, F. Ferrer, I. (2004) Active stress kinase p38 enhances and perpetuates abnormal tau phosphorylation and deposition in Pick's disease. Acta Neuropathol., 107, 185 189.
45. Ralevic, V. Burnstock, G. (1998) Receptors for purines and pyrimidines. Pharmacol. Rev., 50, 413 492.
46. Reppert, S.M., Weaver, D.R., Stehle, J.H. Rivkees, S.A. (1991) Molecular cloning and characterization of a rat A1-adenosine receptor that is widely expressed in brain and spinal cord. Mol. Endocrinol., 5, 1037 1048.
47. Ribeiro, J.A., Sebastiao, A.M. de Mendonca, A. (2003) Participation of adenosine receptors in neuroprotection. Drug News Perspect., 16, 80 86.
48. Rodriguez, A., Freixes, M., Dalfo, E., Martin, M., Puig, B. Ferrer, I. (2005) Metabotropic glutamate receptor/phospholipase C pathway: a vulnerable target to Creutzfeldt-Jakob disease in the cerebral cortex. Neuroscience, 131, 825 832.
49. Rodriguez, A., Martin, M., Albasanz, J.L., Barrachina, M., Espinosa, J.C., Torres, J.M. Ferrer, I. (2006) Adenosine A1 receptor protein levels and activity is increased in the cerebral cortex in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP mice. J. Neuropathol. Exp. Neurol., 65, 964 975.
50. Rudolphi, K.A. Schubert, P. (1997) Modulation of neuronal and glial cell function by adenosine and neuroprotection in vascular dementia. Behav. Brain Res., 83, 123 128.
51. Schindler, M., Harris, C.A., Hayes, B., Papotti, M. Humphrey, P.P. (2001) Immunohistochemical localization of adenosine A1 receptors in human brain regions. Neurosci. Lett., 297, 211 215.
52. Schnecko, A., Witte, K., Bohl, J., Ohm, T. Lemmer, B. (1994) Adenylyl cyclase activity in Alzheimer's disease brain: stimulatory and inhibitory signal transduction pathways are differently affected. Brain Res., 644, 291 296.
53. Schubert, P., Ogata, T., Marchini, C. Ferroni, S. (2001) Glia-related pathomechanisms in Alzheimer's disease: a therapeutic target? Mech. Ageing Dev., 123, 47 57.
54. Schulte, G. Fredholm, B.B. (2000) Human adenosine A (1), A (2A), A (2B), and A (3) receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2. Mol. Pharmacol., 58, 477 482.
55. Selley, M.L. (2004) Increased homocysteine and decreased adenosine formation in Alzheimer's disease. Neurol. Res., 26, 554 557.
56. Sherwood, C.C., Stimpson, C.D., Raghanti, M.A., Wildman, D.E., Uddin, M., Grossman, L.I., Goodman, M., Redmond, J.C., Bonar, C.J., Erwin, J.M. Hof, P.R. (2006) Evolution of increased glia-neuron ratios in the human frontal cortex. Proc. Natl Acad. Sci. USA, 103, 13606 13611.
57. Stone, T.W. (2005) Adenosine, neurodegeneration and neuroprotection. Neurol. Res., 27, 161 168.
58. Svenningsson, P., Hall, H., Sedvall, G. Fredholm, B.B. (1997) Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse, 27, 322 335.
59. Ulas, J., Brunner, L.C., Nguyen, L. Cotman, C.W. (1993) Reduced density of adenosine A1 receptors and preserved coupling of adenosine A1 receptors to G proteins in Alzheimer hippocampus: a quantitative autoradiographic study. Neuroscience, 52, 843 854.
60. Yamamoto, M., Gotz, M.E., Ozawa, H., Luckhaus, C., Saito, T., Rosler, M. Riederer, P. (2000) Hippocampal level of neural specific adenylyl cyclase type I is decreased in Alzheimer's disease. Biochim. Biophys. Acta., 1535, 60 68.
61. Zhukareva, V., Shah, K., Uryu, K., Braak, H., Del Tredici, K., Sundarraj, S., Clark, C., Trojanowski, J.Q. Lee, V.M. (2002) Biochemical analysis of tau proteins in argyrophilic grain disease, Alzheimer's disease, and Pick's disease: a comparative study. Am. J. Pathol., 161, 1135 1141.